Pfizer is increasingly confident that develop his efforts to cow’s crown will be successful. In an interview on July 7 with time, she said CEO of Pfizer Albert Bourla, he believes that the approval of the Food and Drug Administration could come as soon as October. published based on the results of a study in the initial stage and promised on July 1, dramatic Pfizer for the number of doses increases the production this year tens of millions to 100 million projections. Bourla also announced that the company’s trade discussions with governments around the world on how many doses began to receive. Bourla to be $52 billion worldwide pharmaceutical giant believes it is on the right track, which begins to produce the vaccine Pfizer decided before FDA approval received. It is a movement, as risky as is orthodox. Pfizer vaccine, developed by the German biotech partners Biontech, uses a new gene-based approach called messenger RNA; Bourla recognizes that no messenger RNA vaccine has ever been authorized to prevent infectious diseases. The race for a vaccine to be developed is a consequence and urgent scientific challenges of our time, and there are 180 vaccines under development, according to the Milken Institute. Other pharmaceutical CEOs was less aggressive in their predictions, when vaccines are available, suggesting that any vaccine at least a year away. Pfizer will launch a large-scale clinical trial later in July, which involved 30,000 people in 150 locations by the end of the test phase. Bourla, 58, was born in Greece and trained a veterinarian to work against his way up the ranks to Pfizer, to make plans for the vaccine for the price a profit, but believes that governments, the first doses are more vulnerable should deploy not free . Sign up short by clicking the command here. (This interview with Pfizer CEO Albert Bourla was condensed for clarity and processed) What the data show that Pfizer and Biontech published on July 1? What the vaccine has created man for very robust immune response in all individuals receiving the vaccine. And these answers were also able to kill the virus. What we have learned is that this vaccine can neutralize the virus. So it was a great time? For me, it was the moment I saw the data, as well as many other data that we have not yet published, [that] I have to say I thought until now, when we have a vaccine. Now I discuss when we go to have a vaccine. Let’s talk about timing. You said in your answer is not if, but when. So if? Now, let me be precise and to the point here. One, we only know if the vaccine works when we have the final study. We have many indications that I believe that in reality should make … We should be in September arc capable enough time to have the data to tell whether the vaccine works or not and say the FDA. So, for a possible approval in October, if we’re lucky. It’s possible. And when it will be ready for distribution? The most interesting and important is that if the vaccine is successful, which means that if we believe effective and safe, and the FDA believes effective and safe, we doses already produced, which can be easily available. So he never did that before approving started producing pre FDA to ship it to prepare? Never. Customize currently possible vaccine itself or just the bottles and containers will it go? Soon we will start the production of real vaccine. We can not have the bottle, because we are waiting, but there are many steps. They have invested more than $1 billion. What happens when the FDA rejected the vaccine? We will just write it out and call it a day. We cast off. It ‘just lose money. if you have FDA approval in October, in terms of scale, what kind of programs are you expecting? We are going to have this year over a hundred million doses. We become less in October, a little ‘more in November, a little’ more in December. And then there are about 1.1 to 1.3 billion doses in 2021 we are now discussing whether we have a vaccine either. – Albert Bourla, Pfizer CEO with a B or an M in 2021? With a B like my name. How does your CFO feeling on this floor, perhaps to write from the investment in the development of vaccines? It ‘also in charge of production. So he is now in the hot seat. But from the first day it was very clear that this is not as usual. So yes, if you return on investment was calculated, we would never do such things. We discussed that in March, what does this mean for human life, for the world economy. So it was a must that we must take these measures. The time to study, in collaboration with Columbia Business School in a number of on-line, to provide on-demand courses, on topics such as effective leadership, negotiation and customer-oriented marketing. To sign up or learn more, click here. Since the board has to answer? When they heard the planes, they were of great help. And I think that’s what people want to hear our investors that Pfizer can use their resources and may be different, bringing a solution in the world that few can bring. This creates a significant value proposition for the industry and especially for us. I can not compete with the cost, say, $2 billion that we are losing on this thing. This is your total investment, $2 billion? I think that as a whole, and most of it will be this year. You are in regular contact with Dr. Fauci about it? He is aware of our progress. I do not speak for him, but I know he is cautiously optimistic. I use the exact phrase he used cautiously optimistic. Sign up short by clicking the command here. What kind of conversations you have with various governments around the world? Everyone must be made of pre-orders place. And we are in the initial interviews with all of them, trying to see what they need and how we can quantity to associate them in a fair manner. If you look at who is dying of COVID now, and who will jump to the front of the line to be vaccinated will be the last line to skip the broader discussion about the injustices that actually in many ways. But many of the people who die poor, of color, the work in the front. What measures are being taken to ensure a fair distribution of the vaccine? There is no doubt that more minorities are disproportionately affected by COVID-19, and African-Americans, for example, is one of these groups that many, many victims in their population. We ensure that our studies have fair representation of people who have become ill. I believe that the government should set priorities, but the priorities should be the most vulnerable people. You’re a businessman and a scientist, not a politician and moral philosopher. But there is so much social unrest in this country now, it seems that if the vaccine is out there and the elites do so by the front workers, could be a new level of outrage on the streets along the way. I think if something like what you describe happens, it will be a great pity. That would undermine the credibility of our institutions to complete. When you start, it’s a very difficult situation, but follow the agreed requirements clearly to various criteria, and nothing you have to do either the money or the right has now in power. And what is the price? The vaccine should be free for everyone. It should be free? To give away? We do not give away the governments. We will increase the governments … a very, very nominal amount. But our intention is to ask governments that should, for these prices, which should enable all citizens, free of charge. To mainly sell to governments, to the detriment? No, I think we make a profit, but we will make a very, very marginal profit at this stage. And also remember that we did not take and I think that we are so far we are the only ones who know, but do not take money from the US government or any other government in the world. Given the aggressive price increases of Prevnar 13, a vaccine against pneumonia, which is one of your best-selling products, some consumer health advocates concerned about your pricing plans for this vaccine. You’re right that if we were our vaccine based on the price value that it brings, as usual, we go to this level and much higher. But what I say now is that we do not intend to. Because we know that right now the number one understand the idea that everyone is easier, it is very fast. In a not too distant past, the pharmaceutical industry has been vilified for his role in the crisis opioids and predatory pricing. See this as an opportunity to redeem himself for the industry? During the Democratic primary Big Pharma has been named as Big Tobacco. My company has provided medicines that save the lives of 500 million people. And I do not think any other industry can claim the world that produces much good for mankind. Think how many fathers and mothers live long enough to see the division of their daughters. This is because of us. So I’m very proud of the value this brings industry worldwide. It ‘a totally unfair perception, and used by politicians, because it is much scoring, very good. I think COVID-19 is really an opportunity to put the perception. Do not set the value, because the value was there. hope for billions of people, millions of companies and hundreds of governments at this time, we provide a solution to this mess to find. They are passionate entirely on this point. I’m sure you would too if you think that your work in the world and someone a good door that said as tobacco are. It could also be very passionate. They have a PSA that says “Science will win.” I know it is that the political situation is not something you want to Wade, but that feels like a direct comment on administration, leaving in many ways science has. It is not my intention. But it is quite clear that science is everything for us. And it is very clear that we are seeing science the only solution. And we express our trust in the fact that science win. I feel like I should ask of Pfizer’s Viagra. What is the current relative importance of Viagra, which is now patent, say about the nature of the pharmaceutical industry? Viagra is a very big part of our rich history of innovation, because it was unique. I know there were jokes about this product, but for people suffering from a real medical condition that was not a joke. But we are proud of how we are proud of Lipitor (a drug that lowers cholesterol levels and are now available from patent protection), which was much bigger than Viagra and is able to prevent the deaths of hundreds of millions of people. And now it costs a few cents. And it is the same with every product we have now. Soon, they will lose patent, and it will cost a few cents. This is the name of the game. I understand one of the first things you did when you took over as CEO redesign was your office and place of patient images is on your desk or on the wall. whether it is a symbolic step, the culture, what every pharmaceutical company should build helps. A culture of patient-centered. This is all about patient. The only way that a pharmaceutical company to succeed, it is when we create value for patients. There is no other way. The only way that a pharmaceutical company to succeed, it is when we create value for patients. There is no other way. – Albert Bourla, Pfizer CEO of an education as a veterinarian. You have a real veterinary practice? I have practiced in the university clinic. I was a specialist in obstetrics. I was practicing in the maternity hospital. And my PhD Biology Biotechnology was playing in. I did the embryo transfer, fertilization in vivo. Artificial insemination, etc. They were born and raised in Greece. You’ve read Homer in the original as a schoolboy? I did it. And you like the Iliad or Odyssey better? I like the Iliad better. Although the Odyssey is much more adventurous in his way. What is it about the Iliad, it was designed? Why is the policy that love [laughs] and power. In a book. Wag and war. And politics. Unbelievable. – with reporting by Alice favorite Bourla Park BUSINESS BOOK: What brought you here there’s no Marshall Goldsmith obtained. I found myself in it. All the things that describes what people do when they go into higher positions. The error, I found that I did. AUTHOR. I read the Greek authors. The last English book I’m reading now Bad Blood. (Miss this week is the short lead, this interview was given in the brief leadership mailbox participants on the morning of Sunday, July 12? Email conversations obtained with the first CEOs of the world and business decision-makers, click here .) This seems 2020 issue of time July 20. Picture copyright by Robert Duron Courtesy Pfizer
Pfizer CEO Albert Bourla increases expectations that the pharmaceutical giant can COVID-19 vaccine to be delivered case
